Author

Roberta Bonafè

Observed names: R. Bonafè, Roberta Bonafé

Institution: Bracco (Italy)

Observed institution: Bracco (Italy)

ORCID: 0000-0002-0902-7600

Observed ORCID: 0000-0002-0902-7600

OpenAlex ID: A5068103248

Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases

2019 · Cédric Chauvierre, Rachida Aid-Launais, et al. · Marine Drugs · 47

Non-clinical assessment of safety and gadolinium deposition after cumulative administration of gadobenate dimeglumine (MultiHance ® ) to neonatal and juvenile rats

2017 · Simona Bussi, Laure Penard, et al. · Regulatory Toxicology and Pharmacology · 23

In vivo tumor targeting and biodistribution evaluation of paramagnetic solid lipid nanoparticles for magnetic resonance imaging

2016 · Simona Ghiani, Martina Capozza, et al. · Nanomedicine Nanotechnology Biology and Medicine · 21

Comparative assessment of the in vitro toxicity of some functionalized carbon nanotubes and fullerenes

2015 · Carolina Canapè, Stéphanie Foillard, et al. · RSC Advances · 18

Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats

2021 · Simona Bussi, Alessandra Coppo, et al. · Journal of Magnetic Resonance Imaging · 15

Gadolinium retention in a rat model of subtotal renal failure: are there differences among macrocyclic GBCAs?

2023 · Roberta Bonafè, Alessandra Coppo, et al. · European Radiology Experimental · 6

Cytotoxic effects of carbon nanotubes (CNTs) and fullerenes on human fibroblasts: Choosing the best suspension method

2008 · Roberta Bonafè, Paola Bardini, et al. · Toxicology Letters · 2

In vitro toxicity of functionalized MWCNTs and Fullerenes on six mammalian cell lines: Selection and optimization of the proper method to reduce physical–chemical interferences

2009 · Roberta Bonafè, Paola Bardini, et al. · Toxicology Letters · 1

Nonclinical Safety Assessment of Digadoglucitol, a Novel Magnetic Resonance Imaging Contrast Agent for the Central Nervous System.

2026 · Roberta Bonafè, Alessandra Coppo, et al. · PubMed

Mutagenicity assessment of two potential impurities in preparations of 5-amino-2,4,6 triiodoisophthalic acid, a key intermediate in the synthesis of the iodinated contrast agent iopamidol

2023 · Silvia Rossi, Simona Bussi, et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis

P03-06: In silico and in vitro mutagenicity assessment of potential impurities of 5-amino-2,4,6-triiodoisophthalic acid, a key intermediate in the synthesis of the iodinated contrast agent iopamidol

2023 · S. Rossi, S. Bussi, et al. · Toxicology Letters

Cellular toxicity and haemolytic potential of functionalized fullerene and multi-walled carbon nanotubes

2010 · R. Bonafè, S. Bussi, et al. · Toxicology Letters

Works count: 12

Citation count: 133

H-index: 6

I10-index: 5